Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China

Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China

In this study, data of esophageal cancer patients undergoing definitive radiotherapy in 14 institutions from various provinces in China were evaluated to help strengthen confidence in anti-cancer, including rehabilitation, economic burden, and quality of life.

Inclusion Criteria:

1. Patients with esophageal cancer who received definitive radiotherapy (radiotherapy dose ≥50Gy) from 2015 to 2016
2. Age ≥ 18
3. The radiation field included primary esophageal tumor with or without lymph node metastasis

Exclusion Criteria:

1. Radiotherapy dose < 50Gy
2. Palliative radiotherapy
3. The radiation field are metastatic areas, such as bone, brain, adrenal gland, isolated metastatic lymph nodes, etc